Literature DB >> 23620340

Expression of adropin in rat brain, cerebellum, kidneys, heart, liver, and pancreas in streptozotocin-induced diabetes.

Suleyman Aydin1, Tuncay Kuloglu, Suna Aydin, Mehmet Nesimi Eren, Musa Yilmaz, Mehmet Kalayci, Ibrahim Sahin, Nevin Kocaman, Cihan Citil, Yalcin Kendir.   

Abstract

We have investigated how diabetes affects the expression of adropin (ADR) in rat brain, cerebellum, kidneys, heart, liver, and pancreas tissues. The rats in the diabetic group were administered an intraperitoneal (i.p.) injection of a single dose of 60 mg/kg streptozotocin (STZ) dissolved in a 0.1 M phosphate-citrate buffer (pH 4.5). The rats were maintained in standard laboratory conditions in a temperature between 21 and 23 °C and a relative humidity of 70 %, under a 12-h light/dark cycle. The animals were fed a standard commercial pellet diet. After 10 weeks, the animals were sacrified. ADR concentrations in the serum and tissue supernatants were measured by ELISA, and immunohistochemical staining was used to follow the expression of the hormones in the brain, cerebellum, kidneys, heart, liver, and pancreas tissues. The quantities were then compared. Increased ADR immunoreaction was seen in the brain, cerebellum, kidneys, heart, liver, and pancreas in the diabetes-induced rats compared to control subjects. ADR was detected in the brain (vascular area, pia mater, neuroglial cell, and neurons), cerebellum (neuroglial cells, Purkinje cells, vascular areas, and granular layer), kidneys (glomerulus, peritubular interstitial cells, and peritubular capillary endothelial cells), heart (endocardium, myocardium, and epicardium), liver (sinusoidal cells), and pancreas (serous acini). Its concentrations (based on mg/wet weight tissues) in these tissues were measured by using ELISA showed that the levels of ADR were higher in the diabetic rats compared to the control rats. Tissue ADR levels based on mg/wet weight tissues were as follows: Pancreas > liver > kidney > heart > brain > cerebellar tissues. Evidence is presented that shows ADR is expressed in various tissues in the rats and its levels increased in STZ-induced diabetes; however, this effect on the pathophysiology of the disorder remains to be understood.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23620340     DOI: 10.1007/s11010-013-1660-4

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  37 in total

1.  Adropin deficiency is associated with increased adiposity and insulin resistance.

Authors:  K Ganesh Kumar; Jingying Zhang; Su Gao; Jari Rossi; Owen P McGuinness; Heather H Halem; Michael D Culler; Randall L Mynatt; Andrew A Butler
Journal:  Obesity (Silver Spring)       Date:  2012-02-09       Impact factor: 5.002

Review 2.  Diabetes mellitus: new drugs for a new epidemic.

Authors:  G Nicholson; G M Hall
Journal:  Br J Anaesth       Date:  2011-05-24       Impact factor: 9.166

3.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

Review 4.  Islet β-cell ghrelin signaling for inhibition of insulin secretion.

Authors:  Katsuya Dezaki; Toshihiko Yada
Journal:  Methods Enzymol       Date:  2012       Impact factor: 1.600

5.  Long-term, intermittent, insulin-induced hypoglycemia produces marked obesity without hyperphagia or insulin resistance: a model for weight gain with intensive insulin therapy.

Authors:  Ewan C McNay; Jennifer A Teske; Catherine M Kotz; Ambrose Dunn-Meynell; Barry E Levin; Rory J McCrimmon; Robert S Sherwin
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-11-20       Impact factor: 4.310

6.  Identification of nesfatin-1 as a satiety molecule in the hypothalamus.

Authors:  Shinsuke Oh-I; Hiroyuki Shimizu; Tetsurou Satoh; Shuichi Okada; Sachika Adachi; Kinji Inoue; Hiroshi Eguchi; Masanori Yamamoto; Toshihiro Imaki; Koushi Hashimoto; Takafumi Tsuchiya; Tsuyoshi Monden; Kazuhiko Horiguchi; Masanobu Yamada; Masatomo Mori
Journal:  Nature       Date:  2006-10-01       Impact factor: 49.962

7.  Presence of adropin, nesfatin-1, apelin-12, ghrelins and salusins peptides in the milk, cheese whey and plasma of dairy cows.

Authors:  Suleyman Aydin
Journal:  Peptides       Date:  2013-02-27       Impact factor: 3.750

8.  Ghrelin expression in normal kidney tissue and renal carcinomas.

Authors:  Adile F Dagli; Suleyman Aydin; Aziz Karaoglu; Nusret Akpolat; Ibrahim H Ozercan; Mehmet R Ozercan
Journal:  Pathol Res Pract       Date:  2008-12-02       Impact factor: 3.250

9.  The bioactive peptides salusins and apelin-36 are produced in human arterial and venous tissues and the changes of their levels during cardiopulmonary bypass.

Authors:  Suna Aydin; Mehmet Nesimi Eren; Suleyman Aydin; Ibrahim Hanefi Ozercan; Adile Ferda Dagli
Journal:  Peptides       Date:  2012-08-04       Impact factor: 3.750

10.  Nesfatin-1 and ghrelin levels in serum and saliva of epileptic patients: hormonal changes can have a major effect on seizure disorders.

Authors:  Suleyman Aydin; Ersel Dag; Yusuf Ozkan; Fazilet Erman; Adile Ferda Dagli; Nermin Kilic; Ibrahim Sahin; Fikret Karatas; Tahir Yoldas; Abdullah Onder Barim; Yalcin Kendir
Journal:  Mol Cell Biochem       Date:  2009-03-05       Impact factor: 3.396

View more
  43 in total

1.  Adropin preserves the blood-brain barrier through a Notch1/Hes1 pathway after intracerebral hemorrhage in mice.

Authors:  Lingyan Yu; Zhengyang Lu; Sherrefa Burchell; Derek Nowrangi; Anatol Manaenko; Xue Li; Yang Xu; Ningbo Xu; Jiping Tang; Haibin Dai; John H Zhang
Journal:  J Neurochem       Date:  2017-11-17       Impact factor: 5.372

2.  Vasodilatory function in human skeletal muscle feed arteries with advancing age: the role of adropin.

Authors:  Oh Sung Kwon; Robert H I Andtbacka; John R Hyngstrom; Russell S Richardson
Journal:  J Physiol       Date:  2019-02-27       Impact factor: 5.182

3.  A possible connection between tumor necrosis factor alpha and adropin levels in polycystic ovary syndrome.

Authors:  T Kume; M Calan; O Yilmaz; G U Kocabas; P Yesil; M Temur; M Bicer; O G Calan
Journal:  J Endocrinol Invest       Date:  2016-03-11       Impact factor: 4.256

4.  Molecular cloning, characterization and expression of the energy homeostasis-associated gene in piglet.

Authors:  Sheng-ping Wang; Yun-ling Gao; Gang Liu; Dun Deng; Rong-jun Chen; Yu-zhe Zhang; Li-li Li; Qing-qi Wen; Yong-qing Hou; Ze-meng Feng; Zhao-hui Guo
Journal:  J Zhejiang Univ Sci B       Date:  2015-06       Impact factor: 3.066

5.  Serum Adropin Levels Are Reduced in Adult Patients with Nonalcoholic Fatty Liver Disease.

Authors:  Orkide Kutlu; Özgür Altun; Okan Dikker; Şerife Aktaş; Neslihan Özsoy; Yücel Arman; Eylem Özgün Çil; Mustafa Özcan; Şengül Aydın Yoldemir; Murat Akarsu; İlkim Deniz Toprak; Kerem Kırna; Yasin Kutlu; Zeki Toprak; Hasan Eruzun; Tufan Tükek
Journal:  Med Princ Pract       Date:  2019-04-16       Impact factor: 1.927

6.  Adropin acts in brain to inhibit water drinking: potential interaction with the orphan G protein-coupled receptor, GPR19.

Authors:  Lauren M Stein; Gina L C Yosten; Willis K Samson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-01-06       Impact factor: 3.619

7.  Betatrophin provides a new insight into diabetes treatment and lipid metabolism (Review).

Authors:  Jin-Zhou Zhu; Chao-Hui Yu; You-Ming Li
Journal:  Biomed Rep       Date:  2014-05-20

8.  Adropin is a brain membrane-bound protein regulating physical activity via the NB-3/Notch signaling pathway in mice.

Authors:  Chi-Ming Wong; Yudong Wang; Jimmy Tsz Hang Lee; Zhe Huang; Donghai Wu; Aimin Xu; Karen Siu Ling Lam
Journal:  J Biol Chem       Date:  2014-07-29       Impact factor: 5.157

9.  Serum adropin level and ENHO gene expression in systemic sclerosis.

Authors:  Servet Yolbas; Murat Kara; Musa Yilmaz; Suleyman Aydin; Suleyman Serdar Koca
Journal:  Clin Rheumatol       Date:  2016-04-15       Impact factor: 2.980

10.  Association between serum adropin level and coronary artery disease: a systematic review and meta-analysis.

Authors:  Jiankang Zheng; Mao Liu; Ling Chen; Feng Yin; Xiao Zhu; Junqi Gou; Wei Zeng; Zhan Lv
Journal:  Cardiovasc Diagn Ther       Date:  2019-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.